Response to Chalassani et al.
Primus Pharmaceuticals, Inc., Clinical Development, Scottsdale, Arizona, USA.
Robert
R
Levy
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis* / Q000628:therapy*; D019587:Dietary Supplements / Q000009:adverse effects*; D006801:Humans; D028321:Plant Preparations / Q000009:adverse effects*
D028321:Plant Preparations